Status:
COMPLETED
Validation of the GATE Software
Lead Sponsor:
University Hospital Tuebingen
Collaborating Sponsors:
Haag-Streit AG
Conditions:
Visual Field Defects
Eligibility:
All Genders
18+ years
Brief Summary
Comparison of the differential luminance sensitivity (DLS) values at each test point
Eligibility Criteria
Inclusion
- physical, intellectual and linguistic abilities, in order to understand the test requirements
- spherical ametropia max. ± 8 dpt, cylindrical ametropia max. ± 3 dpt
- distant visual acuity \> 10/20
- isocoria, pupil diameter \> 3 mm
Exclusion
- pregnancy, nursing
- diabetic retinopathy
- asthma
- HIV+ or AIDS
- history of epilepsy or significant psychiatric disease
- medications known to effect visual field sensitivity
- acute ocular infections (e.g. keratitis, conjunctivitis, uveitis)
- severe dry eyes
- miotic drugs
- amblyopia
- squint
- nystagmus
- albinism
- keratoconus
- intraocular surgery (except for uncomplicated cataract surgery) performed \< 3 month prior to screening
- history or presence of macular disease and / or macular edema
- relevant opacities of central refractive media (cornea, lens, vitreous body)
- ocular trauma
Key Trial Info
Start Date :
November 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01265628
Start Date
November 1 2010
Last Update
January 26 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre for Ophthalmology, Institute for Ophthalmic Research
Tübingen, Germany, 72076